New Hope for Biliary Tract Cancer Patients: The Microbiome Connection
Biliary tract cancer (BTC) has long been a challenging disease to treat. Traditionally, doctors relied on a combination of cisplatin and gemcitabine as the go-to treatment. But things are changing. Adding durvalumab, a type of immunotherapy, to this mix has shown promising results. It's making a real difference in how long patients live. So, what's the big deal abou...